Market Research Report
Europe Western Blotting Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||823181|
|Published||Content info||82 Pages
Delivery time: 2-3 business days
|Europe Western Blotting Market Forecast 2019-2027|
|Published: April 15, 2019||Content info: 82 Pages||
The western blotting market supplies the required devices and other products that are needed for this laboratory method used to identify specific protein molecules from a mixture of proteins. The Europe market for western blotting had generated a revenue of $XX million in 2018 and is projected to obtain $XX million revenue by 2027, at a CAGR of 4.66% during the forecasting years of 2019-2027.
The Europe western blotting market report mainly covers the analysis of the countries such as the United Kingdom, France, Italy, Germany, Spain and the Rest of Europe. The United Kingdom western blotting market generated a revenue of $XX million in 2018 and is projected to reach $XX million by 2027, at a CAGR of XX% owing to the presence of favorable reimbursement policies, and government reforms are boosting the growth of the market in the forecast period 2019-2027.
Also, the major players in this country are undertaking strategic steps such as merger & acquisitions, new product developments, partnership agreements, and distribution agreements to increase their market share and further boosting the market growth in the region.
Merck KGaA, Thermo Fisher Scientific Ltd., Li-Cor Inc., Bio-Techne Corporation, GE Healthcare, PerkinElemer Inc., F. Hoffman La-Roche Ltd., Rockland Immunochemicals Inc., Lumigen Inc., Advansta, Cell Signaling Technology Inc., Roche Diagnostics, Roche Diagnostics International Ltd., Bio-Rad Technologies Inc., and Azure Biosystems Inc. are the eminent companies functioning in the market which have been extensively profiled in the report.